Who gets access and how fast will determine Lenacapavir's impact.

Simple item page
dc.contributor.authorLusimbo, Richard
dc.date.accessioned2026-07-30T13:41:47Z
dc.date.available2026-07-30T13:41:47Z
dc.date.issued2026-03-09
dc.descriptionNewspaper article
dc.description.abstractLong-acting HIV prevention options like Lenacapavir are genuine game changer for communities facing stigma, legal barriers, and daily adherence challenges. For a young woman navigating an abusive relationship, or sex worker afraid to be seen at a clinic, a twice-yearly injection removes many of the barriers that daily prevention pills cannot overcome.
dc.identifier.citationLusimbo, R. (2026). Who gets access and how fast will determine Lenacapavir's impact. Daily Monitor.
dc.identifier.urihttps://bdears.busitema.ac.ug/handle/123456789/8437
dc.language.isoen
dc.publisherDaily Monitor
dc.titleWho gets access and how fast will determine Lenacapavir's impact.
dc.typeArticle
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
Lusimbo-Richard-09-03-2026.pdf
Size:
2.83 MB
Format:
Adobe Portable Document Format
Description:
Newspaper article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed to upon submission
Description:
Download
Collections
Faculty of Health Sciences